Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2023 09:50 ET | Source: Sirona Biochem Corp.

Sirona Biochem Initiates GlycoProteMim™ Trademark for Anti-Aging Molecule TFC-1326

VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF), is making a strategic move in the world of advanced skincare solutions....
December 07, 2023 15:17 ET | Source: Ulta-Lit Tree Company

Ulta-Lit wins 3-year IP battle but now faces new problem with the same AZ firm

Ulta-Lit wins 3-year IP battle but now faces new problem with the same AZ firm
December 06, 2023 18:00 ET | Source: MediciNova, Inc.

MediciNova Receives a Notice of Decision to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS in Europe

LA JOLLA, Calif., Dec. 06, 2023 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange...
December 05, 2023 09:44 ET | Source: The Akkermansia Company

The Akkermansia Company Found to be ‘First to File’ Patent Application to Treat Obesity Through Oral Use of the Probiotic Akkermansia

The Akkermansia Company was found to be the "first to file" a patent application to treat obesity through oral use of the probiotic Akkermansia.
December 05, 2023 08:30 ET | Source: Checkpoint Therapeutics, Inc

Checkpoint Therapeutics Strengthens Intellectual Property Protection for Cosibelimab with New U.S. Patent Issuance

Upcoming PDUFA goal date of January 3, 2024 U.S. patent protection for cosibelimab through at least May 2038 WALTHAM, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc....
December 04, 2023 08:30 ET | Source: Mycotopia Therapies Inc.

Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million

MIAMI, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (“Mycotopia Therapies”) (“the Company”) (OTC: TPIA) announced today it has purchased certain assets of Philon Labs, LLC ("Philon...
November 30, 2023 12:01 ET | Source: Movi Family LLC

Movi Family LLC files Motion to Dismiss Patent Infringement Case For Its Innovative Changing Pad

Pasadena, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Movi Family LLC (“Movi"), a family-owned baby brand, has filed a Motion to Dismiss a competitor lawsuit baldly alleging design patent and trade dress...
November 30, 2023 07:00 ET | Source: Renexxion LLC

Renexxion Ireland Announces Issuance of Two U.S. Patents Covering a Novel Crystal Isoform of Naronapride

ROSCREA, Ireland, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high unmet...
November 30, 2023 07:00 ET | Source: Algernon Pharmaceuticals

Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD

VANCOUVER, British Columbia, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a Canadian clinical stage...
November 28, 2023 13:24 ET | Source: AIM ImmunoTech Inc.

AIMイムノテック (AIM ImmunoTech)、2つの重要な米国特許を取得し、Ampligen®の知的財産を強化

癌･ME/CFS治療薬Ampligenの米国における独占権を2039年まで延長経営陣が特許の取得とその意味について簡単な動画で説明している。こちらフロリダ州オカラ発 , Nov. 29, 2023 (GLOBE NEWSWIRE) -- AIMイムノテック (AIM ImmunoTech Inc.) (NYSE American: AIM) (「AIM」または「同社」)...